financial guidance Oct 28, 2021 Merck Q3 Revenues Grow 20 Percent With Keytruda as Top Seller Jan 11, 2021 Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan Oct 30, 2019 Exact Sciences Preparing to Launch Improved Cologuard, Liver Cancer Test Premium Jul 29, 2019 Exact Sciences to Acquire Genomic Health for $2.8B; Q2 Revenues Rise 94 Percent Apr 30, 2019 Exact Sciences Q1 Revenues Up 79 Percent Breaking News Marengo Therapeutics Begins Phase I/II Trial of Selective T-Cell-Targeted Antibody Janssen, Legend Biotech's Carvykti Bests Chemo in Earlier-Line Multiple Myeloma Trial In Brief This Week: PreludeDx, Johnson & Johnson, Syros, Magenta, Merck NICE Backs Gilead Sciences' Yescarta as Third-Line Option for Lymphoma Patients BMS Eyeing Breyanzi Indications in CLL, SLL After Positive Trial Data Enhertu Approved in Europe for HER2-Low Metastatic Breast Cancer
